Changhai Lei

1.6k total citations · 1 hit paper
33 papers, 1.1k citations indexed

About

Changhai Lei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Changhai Lei has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Immunology. Recurrent topics in Changhai Lei's work include Extracellular vesicles in disease (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and CAR-T cell therapy research (7 papers). Changhai Lei is often cited by papers focused on Extracellular vesicles in disease (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and CAR-T cell therapy research (7 papers). Changhai Lei collaborates with scholars based in China, Japan and United States. Changhai Lei's co-authors include Shi Hu, Wenyan Fu, Kewen Qian, Min Ding, Li Tian, Yafeng Shen, Sheng Zhang, Fangxing Lin, Yongji Yang and Xiaoyan Fan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Changhai Lei

30 papers receiving 1.1k citations

Hit Papers

CAR exosomes derived from effector CAR-T cells have poten... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changhai Lei China 14 588 295 282 270 243 33 1.1k
Kewen Qian China 7 456 0.8× 293 1.0× 206 0.7× 157 0.6× 200 0.8× 13 831
Jinsong Hu China 19 747 1.3× 301 1.0× 278 1.0× 391 1.4× 344 1.4× 50 1.5k
Alexandra Flemming United States 16 526 0.9× 115 0.4× 554 2.0× 237 0.9× 125 0.5× 177 1.3k
Maria Laura De Angelis Italy 18 509 0.9× 245 0.8× 116 0.4× 516 1.9× 286 1.2× 34 1.1k
Xiangyi Ma China 21 519 0.9× 59 0.2× 161 0.6× 270 1.0× 162 0.7× 48 1.2k
Yi-Zhou Jiang China 20 1.1k 1.9× 173 0.6× 112 0.4× 139 0.5× 499 2.1× 35 1.5k
Ryan D. Chow United States 21 1.2k 2.0× 99 0.3× 355 1.3× 661 2.4× 195 0.8× 40 1.9k
Meng Wu China 12 485 0.8× 94 0.3× 463 1.6× 513 1.9× 75 0.3× 31 1.2k
Ryan Duggan United States 12 622 1.1× 335 1.1× 1.3k 4.6× 584 2.2× 184 0.8× 21 1.8k
Kelsey Voss United States 14 474 0.8× 110 0.4× 500 1.8× 308 1.1× 321 1.3× 22 1.2k

Countries citing papers authored by Changhai Lei

Since Specialization
Citations

This map shows the geographic impact of Changhai Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changhai Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changhai Lei more than expected).

Fields of papers citing papers by Changhai Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changhai Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changhai Lei. The network helps show where Changhai Lei may publish in the future.

Co-authorship network of co-authors of Changhai Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Changhai Lei. A scholar is included among the top collaborators of Changhai Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changhai Lei. Changhai Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tiantian, et al.. (2025). Research progress of antibody coupling technique in targeted drug delivery. SHILAP Revista de lepidopterología. 3(3).
2.
Lei, Changhai, et al.. (2025). Dual-target immunotherapies in NSCLC: a systematic review and meta-analysis of randomized clinical trials. Frontiers in Immunology. 16. 1605877–1605877.
3.
Zhou, Yaping, Dan Tan, Guangyao Li, et al.. (2025). Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies. Journal of Pharmaceutical Analysis. 16(2). 101417–101417.
4.
Li, Guangyao, et al.. (2024). The therapeutic potential of exosomes in immunotherapy. Frontiers in Immunology. 15. 1424081–1424081. 10 indexed citations
5.
Qian, Kewen, Guangyao Li, Shuyi Zhang, et al.. (2024). The application of antibody-based agents in cancer therapy based on their mechanisms of action. Fundamental Research. 5(5). 2343–2360. 3 indexed citations
6.
Qian, Kewen, Guangyao Li, Shuyi Zhang, et al.. (2024). Small extracellular vesicles purification and scale-up. Frontiers in Immunology. 15. 1344681–1344681. 19 indexed citations
7.
Li, Guangyao, et al.. (2024). Exosomes of immune cell origin and their therapeutic potential for tumors. SHILAP Revista de lepidopterología. 5(5). 18 indexed citations
8.
Zhang, Shuyi, Guangyao Li, Kewen Qian, et al.. (2024). Exosomes derived from cancer cells relieve inflammatory bowel disease in mice. Journal of drug targeting. 32(9). 1073–1085. 1 indexed citations
9.
Qian, Kewen, Guangyao Li, Shuyi Zhang, et al.. (2024). CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies. SHILAP Revista de lepidopterología. 2(2). 19 indexed citations
10.
Fu, Wenyan, Guangyao Li, Changhai Lei, et al.. (2023). Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency. Theranostics. 13(11). 3641–3654. 5 indexed citations
11.
Fu, Wenyan, Changhai Lei, Chuqi Wang, et al.. (2022). Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy. Nature Biomedical Engineering. 6(7). 842–854. 12 indexed citations
12.
Qian, Kewen, Wenyan Fu, Tian Li, et al.. (2022). The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy. Journal of Experimental & Clinical Cancer Research. 41(1). 286–286. 49 indexed citations
13.
Shen, Xian, Wenyan Fu, Yongpeng Wei, et al.. (2021). TIGIT-Fc Promotes Antitumor Immunity. Cancer Immunology Research. 9(9). 1088–1097. 10 indexed citations
14.
Fu, Wenyan, Changhai Lei, Kewen Qian, et al.. (2021). CAR Macrophages for SARS-CoV-2 Immunotherapy. Frontiers in Immunology. 12. 669103–669103. 25 indexed citations
15.
Fu, Wenyan, et al.. (2021). TIGIT-Fc as a Potential Therapeutic Agent for Fetomaternal Tolerance. Frontiers in Immunology. 12. 649135–649135. 10 indexed citations
16.
Fu, Wenyan, Changhai Lei, Yue Yu, et al.. (2019). EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency. Clinical Cancer Research. 25(9). 2835–2847. 29 indexed citations
17.
18.
Hu, Shi, Haibin Dai, Tian Li, et al.. (2016). Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer. Cancer Letters. 382(1). 32–43. 22 indexed citations
19.
Song, Xiaowei, et al.. (2015). In situ visualizing T-Tubule/SR junction reveals the ultra-structures of calcium storage and release machinery. International Journal of Biological Macromolecules. 82. 7–12. 1 indexed citations
20.
Hu, Shuting, Yafeng Shen, Changhai Lei, et al.. (2009). Altered intracellular Ca2+ regulation in chronic rat heart failure. The Journal of Physiological Sciences. 60(2). 85–94. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026